PMID- 25352937 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20141029 LR - 20181113 IS - 0011-393X (Print) IS - 1879-0313 (Electronic) IS - 0011-393X (Linking) VI - 76 DP - 2014 Dec TI - The Tumor Necrosis Factor-alpha-308 and -238 Polymorphisms and Risk of Hepatocellular Carcinoma for Asian Populations: A Meta-Analysis. PG - 70-5 LID - 10.1016/j.curtheres.2014.04.001 [doi] AB - BACKGROUND: Tumor necrosis factor-alpha (TNF-alpha) has been suggested to play a very important role in the development and progression of hepatocellular carcinoma (HCC). Many studies have identified the associations of TNF-alpha-308 and -238 polymorphisms with HCC risk, but the results remain controversial. AIM: We conducted this meta-analysis to evaluate the associations between TNF-alpha-308 and -238 polymorphisms and HCC susceptibility. METHODS: PubMed, Embase, and China National Knowledge Infrastructure electronic databases were searched for all articles on associations between TNF-alpha-308 and -238 polymorphisms and HCC risk in Asians through September 30, 2013. Odds ratios (ORs) and their 95% CIs were calculated to assess the strength of this association. RESULTS: A total of 17 case-control studies were identified in our meta-analysis. For the TNF-alpha-308 G/A polymorphism, 14 studies containing 3154 cases and 3767 controls were included. Overall, the frequency of the A allele was higher in patients with HCC than in the healthy controls (10.2% vs 7.5%), and the A allele and allele carrier were significantly associated with increased risk of HCC in a random effects model (A vs G: OR = 1.57; 95% CI, 1.22-2.01; P = 0.0004; AA + AG vs GG: OR = 1.62; 95% CI, 1.18-2.22; P = 0.003). For the TNF-alpha-238 polymorphism, 10 research articles were identified. No association was found between the TNF-alpha-238 G/A polymorphism and risk of HCC in any genetic models (P > 0.05). The sensitivity analysis further strengthened the overall correlations. CONCLUSIONS: Our meta-analysis proved that the TNF-alpha-308 G/A polymorphism is associated with increased susceptibility to HCC. However, the TNF-alpha-238 G/A polymorphism is not significantly associated with risk of HCC in Asian populations. Further studies with large sample sizes are needed to confirm these associations among other populations. FAU - Hu, Qing AU - Hu Q AD - The Second Affiliated Hospital, Zhejiang Traditional Chinese Medical University , Hangzhou, China. FAU - Lou, Guo-Guang AU - Lou GG AD - The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. FAU - Liu, Ying-Chao AU - Liu YC AD - The Second Affiliated Hospital, Zhejiang Traditional Chinese Medical University , Hangzhou, China. FAU - Qian, Le AU - Qian L AD - The Second Affiliated Hospital, Zhejiang Traditional Chinese Medical University , Hangzhou, China. FAU - Lv, Bo-Dong AU - Lv BD AD - The Second Affiliated Hospital, Zhejiang Traditional Chinese Medical University , Hangzhou, China. LA - eng PT - Journal Article DEP - 20140927 PL - United States TA - Curr Ther Res Clin Exp JT - Current therapeutic research, clinical and experimental JID - 0372621 PMC - PMC4209508 OTO - NOTNLM OT - hepatocellular carcinoma OT - meta-analysis OT - polymorphism OT - tumor necrosis factor-alpha EDAT- 2014/10/30 06:00 MHDA- 2014/10/30 06:01 PMCR- 2014/09/27 CRDT- 2014/10/30 06:00 PHST- 2014/04/12 00:00 [accepted] PHST- 2014/10/30 06:00 [entrez] PHST- 2014/10/30 06:00 [pubmed] PHST- 2014/10/30 06:01 [medline] PHST- 2014/09/27 00:00 [pmc-release] AID - S0011-393X(14)00005-8 [pii] AID - 10.1016/j.curtheres.2014.04.001 [doi] PST - epublish SO - Curr Ther Res Clin Exp. 2014 Sep 27;76:70-5. doi: 10.1016/j.curtheres.2014.04.001. eCollection 2014 Dec.